Oct 26 (Reuters) - Concordia Healthcare Corp CXR.TO :
* Announces preliminary 2016 guidance
* Sees FY 2016 revenues of US$1,020 million to US$1,060 million
* Sees 2016 adjusted earnings per share of US$6.29 to US$6.77
* Sees 2016 adjusted EBITDA of US $610 million to US$640 million
* Says change in management of its Barbados operations, Concordia
Pharmaceuticals Inc and Concordia Laboratories Inc
* In 2016, the company anticipates that approximately 60 percent of revenues
will be generated outside the United States
* Expects high single-digit revenue growth over the next three years
(2015-2018)
* FY 2016 earnings per share view $6.98, revenue view $981.1 million -- Thomson
Reuters I/B/E/S
* Says arijit mookerjee, in addition to role as CFO of Barbados operations,
will be appointed managing director
* During 2015-2018 period, the company's non-u.s. revenues are expected to grow
at mid-teen rates
Source text for Eikon urn:newsml:reuters.com:*:nPnch4s0c
Further company coverage CXR.TO